Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
7 participants
INTERVENTIONAL
2022-06-14
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced Satiety With Pork Products Containing Dietary Fibre
NCT02521805
Effect of Potato Fiber on Appetite and Fecal Fat Excretion
NCT02957318
The Effect of Dietary Fiber on Food Liking
NCT03241238
The Effect of Macronutrients on Fibroblast Growth Factor 21 (FGF21) Secretion
NCT05061485
Effects of Dietary Carbohydrate and Fat on Hormones
NCT00016848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control - High Fibre - Low Fibre (CTRL - HF - LF)
* Phase 1 - CTRL: Control diet with moderate fibre consumption for 13days.
* Phase 2 - HF: ad libitum consumption of HF meals for 13days.
* Phase 3 - LF: ad libitum consumption of LF meals for 13days.
Phase 1 - Control
Control diet (30% Fat, 15% Protein, 55% Carbohydrate, Fibre rising from 10 to 16g/d).
Fed to energy balance (1.5 x Resting Metabolic Rate, RMR).
Phase 2 - High Fibre
High Fibre diet (30% Fat, 15% Protein, 55% Carbohydrate, 30g/day Fibre). Fed ad libitum, contains 20g/day pectin (split over breakfast, lunch and dinner) in drinks/yoghurts which will be compulsory to consume and 10g/day fibre coming from the diet provided.
Phase 3 - Low Fibre
Low Fibre diet (30% Fat, 15% Protein, 55% Carbohydrate, 10g/day Fibre). Fed ad libitum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phase 1 - Control
Control diet (30% Fat, 15% Protein, 55% Carbohydrate, Fibre rising from 10 to 16g/d).
Fed to energy balance (1.5 x Resting Metabolic Rate, RMR).
Phase 2 - High Fibre
High Fibre diet (30% Fat, 15% Protein, 55% Carbohydrate, 30g/day Fibre). Fed ad libitum, contains 20g/day pectin (split over breakfast, lunch and dinner) in drinks/yoghurts which will be compulsory to consume and 10g/day fibre coming from the diet provided.
Phase 3 - Low Fibre
Low Fibre diet (30% Fat, 15% Protein, 55% Carbohydrate, 10g/day Fibre). Fed ad libitum.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* low habitual fibre intake (\<10g/day)
Exclusion Criteria
* statins (current)
* aspirin or other NSAIDs or anti-coagulants (current)
* anti-depressants (current)
* smoking or vaping
* Females who are planning to be pregnant, are pregnant or are breastfeeding
* Anyone with food allergies, self-reported food sensitivity or intolerance
* Anyone with coeliac disease or gluten intolerance
* Anyone taking medication which may affect their appetite
* Anyone with an eating disorder
* Anyone with diabetes
* Anyone with a gastrointestinal disorder, kidney disease, liver disease or gout
* Anyone suffering from a psychiatric disorder or any type of substance abuse
* Anyone suffering from unregulated thyroid disease
* Anyone following a vegetarian or vegan diet
* Anyone following a weight loss programme (that may be affecting lifestyle, physical activity \& diet)
* Anyone with unsuitable veins for blood sampling
* Anyone who is unable to fluently speak, read and understand English
* Anyone who is unable to comply to an alcohol-free diet for 6 weeks
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aberdeen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra Johnstone, Prof
Role: PRINCIPAL_INVESTIGATOR
Rowett Institute, University of Aberdeen
Alexander Ross, Dr
Role: PRINCIPAL_INVESTIGATOR
Rowett Institute, University of Aberdeen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rowett Institute, University of Aberdeen
Aberdeen, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
813
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.